Ge He

SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous Cap as potential immunomodulatory agents for cancer therapy.

Xiaodong Ma, Xiaoqing Lv, Jian Guo, 2022, Bioorganic chemistry.

Plasma synthesized molybdenum derived nano-fiber films: The influence of surface composition on their SERS effect

Xinchun Mao, F. Gou, Zongbiao Ye, 2022, Journal of Physics and Chemistry of Solids.

Identification of PI3K/HDAC Dual-targeted inhibitors with subtype selectivity as potential therapeutic agents against solid Tumors: Building HDAC6 potency in a Quinazolinone-based PI3Kδ-selective template.

Yang Wang, Yujie Wang, Xiao-ju Ma, 2022, Bioorganic & medicinal chemistry.

Nitrogen cold plasma treatment stabilizes Cu0/Cu+ electrocatalysts to enhance CO2 to C2 conversion

Junqiang Xu, Qiang Zhang, Wei Li, 2023, Journal of Energy Chemistry.

Discovery of selective HDAC6 inhibitors capped by flavonoid or flavonoid-analogous moieties as anti-cancer therapeutics simultaneously harboring anti-proliferative and immunomodulatory activities.

Xiaodong Ma, Zeng Li, Mingming Zhang, 2022, Bioorganic chemistry.

Directly Suppressing MYC Function with Novel Alkynyl-Substituted Phenylpyrazole Derivatives that Induce Protein Degradation and Perturb MYC/MAX Interaction.

Ge He, Zhi Li, Fang Fang, 2024, Journal of medicinal chemistry.